Free shipping on orders over $150  |  All products third-party tested for 99%+ purity Shop Now

Is PT-141 FDA Approved?

Learn about PT-141's FDA approval status. Bremelanotide was approved as Vyleesi in 2019 for HSDD in women. Details on what the approval covers and off-label use.

Reviewed by Form Blends Medical Team|Updated March 2026

Is PT-141 FDA Approved?

Yes, PT-141 (bremelanotide) is FDA approved. The FDA approved it in June 2019 under the brand name Vyleesi for treating acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women . This makes bremelanotide the first and only FDA-approved self-administered injectable treatment specifically designed to address low sexual desire.

Detailed Answer

The FDA approval of PT-141 is a significant milestone in sexual health medicine. Here is what the approval covers, what it does not, and what it means for people interested in using PT-141.

What the FDA Approved

The FDA approved bremelanotide (Vyleesi) based on two Phase 3 clinical trials known as the RECONNECT studies. These trials enrolled over 1,200 premenopausal women with acquired, generalized HSDD . Key findings included:

  • Statistically significant increases in sexual desire scores compared to placebo.
  • Meaningful reductions in distress associated with low sexual desire.
  • Benefits were observed across multiple measures of sexual function.
  • The drug was generally well tolerated, with nausea being the most common side effect.

The approval specified:

  • Indication: Acquired, generalized HSDD in premenopausal women (not lifelong HSDD or situational HSDD).
  • Route: Subcutaneous injection in the abdomen.
  • Dose: 1.75mg, administered at least 45 minutes before anticipated sexual activity.
  • Limits: No more than one dose per 24 hours and no more than 8 doses per month.

What the Approval Does Not Cover

  • PT-141 use in men (though off-label prescribing is legal)
  • PT-141 use in postmenopausal women (also available off-label)
  • Compounded formulations (these are regulated separately under compounding pharmacy laws)
  • Other delivery methods like nasal spray (the FDA specifically rejected this route due to blood pressure concerns)

Off-Label Prescribing

Physicians in the United States can legally prescribe FDA-approved medications for uses beyond their specific approved indication. This is called off-label prescribing, and it is a standard, widely accepted medical practice . Many men and postmenopausal women use PT-141 through off-label prescriptions with good results. is pt-141 legal in the us

What You Need to Know

  • PT-141 has full FDA approval. It is not an experimental drug or an unproven supplement.
  • The approval is specifically for premenopausal women with HSDD, but off-label use for men and other populations is legal and common.
  • The clinical trial data supporting the approval was strong: two large, well-designed Phase 3 studies.
  • Compounded PT-141 contains the same active ingredient as brand-name Vyleesi and is prepared by licensed pharmacies under regulatory oversight. pt-141 cost per month
  • The FDA's approval gives PT-141 a level of scientific validation that many other peptides do not have.

Is PT-141 FDA approved for men?

PT-141 is not specifically FDA approved for men. The FDA approval covers only premenopausal women with HSDD. However, physicians can and do prescribe PT-141 off-label for men. Off-label prescribing is legal and common in the United States, and clinical studies in men have shown favorable results for sexual desire and function. pt-141 side effects men

What did the FDA clinical trials show?

The FDA approval was based on two large randomized, double-blind, placebo-controlled trials (RECONNECT studies) involving over 1,200 premenopausal women. The trials showed statistically significant improvements in sexual desire and reductions in distress related to low desire compared to placebo. These are considered high-quality clinical trials. pt-141 research studies

Is compounded PT-141 FDA approved?

Compounded medications, including compounded PT-141, are not individually FDA approved. However, compounding pharmacies operate under FDA oversight (section 503A or 503B) and state regulatory frameworks. The active ingredient in compounded PT-141 is the same bremelanotide that the FDA approved in Vyleesi. Many patients choose compounded PT-141 because it is significantly more affordable. where to buy pt-141 online

Access FDA-Recognized PT-141 Through Form Blends

At Form Blends, we prescribe PT-141 through our physician-supervised telehealth platform. Our pharmacy partners are licensed and regulated, and our medical team ensures your protocol aligns with current clinical evidence. Start your consultation today.

Related Articles

Peptide Therapy

Is BPC-157 FDA Approved?

Is BPC-157 FDA approved? Learn about BPC-157's regulatory status, why it hasn't gone through FDA approval, and how physician-supervised access works.

Peptide Therapy

Is BPC-157 FDA Approved?

BPC-157 is not FDA approved for any medical condition. It is available through compounding pharmacies under physician prescription and remains under preclinical investigation.

Peptide Therapy

Is TB-500 FDA Approved?

Learn whether TB-500 is FDA approved. Understand the regulatory status of TB-500, how compounding pharmacies fit in, and what this means for patients.

Peptide Therapy

Is Sermorelin Fda Approved?

Understand sermorelin's FDA approval history, why the branded product was discontinued, and how compounded sermorelin is regulated and prescribed today.

Peptide Therapy

Is CJC-1295 FDA Approved?

Is CJC-1295 FDA approved? Learn about its regulatory status, why it has not received FDA approval, how it is legally accessed through compounding pharmacies, and what this means for safety.

Peptide Therapy

Is Ipamorelin FDA Approved?

Learn whether ipamorelin is FDA approved, its current regulatory status in the US, and how it is legally prescribed through compounding pharmacies and telehealth providers.

← Back to Peptide Therapy